Silver Book Fact

The direct and indirect costs of breast cancer in the U.S. are about $2.35 and $3.13 billion annually. Close to $2 billion of that total is spent on late stage treatment.

Radice, Davide, and Alberto Redaelli. Breast Cancer Management: Quality-of-life and cost considerations. Pharmacoeconom. 2003; 21(6): 383-396. https://link.springer.com/article/10.2165/00019053-200321060-00003

Reference

Title
Breast Cancer Management: Quality-of-life and cost considerations
Publication
Pharmacoeconom
Publication Date
2003
Authors
Radice, Davide, and Alberto Redaelli
Volume & Issue
Volume 21, Issue 6
Pages
383-396
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Spending on cancer medicines represented approximately one percent of the total national health expenditures in 2011.  
  • A man between 65 and 74 is 167.2 times more likely to develop prostate cancer than a male under age 50.  
  • Total annual medical expenditures are $4,187 higher for men with cancer, and $3,293 higher for women with cancer, compared with individuals without a history of the disease.  
  • Men have nearly a one in two chance of developing cancer in their lifetime. For women, the risk is around one in three.  
  • About 35,720 new cases of cancer of the oral cavity are expected in 2009.